Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
145
天
Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery
作者
Jun‐Jie Wang; Ya Gao; Xin‐Qian Ji; Jia‐Yi Yin; Meng‐Zhi Zhang; Bo Wang; Hui‐Min Liu; Siqi Feng; Ning Wang; Guo‐Liang Lu; Yan Li; Piet Herdewijn; Yi‐Chao Zheng; Peng Yan; Xing‐Jie Dai展开收起
作者单位
1. State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Key Laboratory of Henan Province for Small Molecule Drug Discovery and Application, School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China; 2. School of Chinese Medicine University of Hong Kong Hong Kong; 3. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand; 4. Maurice Wilkins Centre The University of Auckland Auckland New Zealand; 5. Department of Biomedicine and Medical Diagnostics, School of Science Auckland University of Technology Auckland New Zealand; 6. XNA Platform, School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China; 7. Rega Institute for Medical Research, Medicinal Chemistry KU Leuven Leuven Belgium; 8. Orthopedic Ward 3, The Fifth Affiliated Hospital of Zhengzhou University Zhengzhou China展开收起
134
天
Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies
作者
Ahmed A. Al‐Karmalawy; Wolfgang Sippl; Abdullah Al‐Dakhil; Tarek A. Yousef; Arwa Omar Al Khatib; Samia S. Hawas展开收起
作者单位
1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Horus University‐Egypt New Damietta Egypt; 2. Department of Medicinal Chemistry, Institute of Pharmacy Martin‐Luther‐University of Halle‐Wittenberg Halle Germany; 3. College of Science, Chemistry Department Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh Saudi Arabia; 4. Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan展开收起
198
天
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
作者
Amandeep Thakur; Mandeep Rana; Sakshi Vanjani; Kei‐Chi Liou; Rajeev Taliyan; Kunal Nepali; Chih‐Hao Yang展开收起
作者单位
1. School of Pharmacy, College of Pharmacy Taipei Medical University Taipei Taiwan; 2. Molecular Medicine University of South Florida Tampa Florida USA; 3. Department of Pharmacy Birla Institute of Technology & Science Pilani Rajasthan India; 4. Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy Taipei Medical University Taipei Taiwan; 5. Department of Pharmacology, School of Medicine, College of Medicine Taipei Medical University Taipei Taiwan; 6. Research Center for Neuroscience Taipei Medical University Taipei Taiwan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天